Home  »  Stock   »  Virax Biolabs Group Limited (VRAX): Lucky investor...

Virax Biolabs Group Limited (VRAX): Lucky investors are lined up for success

Virax Biolabs Group Limited (VRAX) is priced at $3.42 after the most recent trading session. At the very opening of the session, the stock price was $2.64 and reached a high price of $2.64, prior to closing the session it reached the value of $2.47. The stock touched a low price of $2.42.Recently in News on September 20, 2022, Virax Biolabs Introduces Monkeypox Virus Antigen Rapid Test Kit. Kits available in September for Distribution. You can read further details here

Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Virax Biolabs Group Limited shares are logging -88.21% during the 52-week period from high price, and 41.32% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $2.42 and $29.00.

Top 5 Cheap Stocks to Own Right Now

While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.

Sign up here to get your free report now. .


The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 45581175 for the day, which was evidently higher, when compared to the average daily volumes of the shares.

When it comes to the year-to-date metrics, the Virax Biolabs Group Limited (VRAX) recorded performance in the market was -86.43%. At the time of this writing, the total market value of the company is set at 31.54M, as it employees total of 6 workers.

Specialists analysis on Virax Biolabs Group Limited (VRAX)

During the last month, 0 analysts gave the Virax Biolabs Group Limited a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.

Trends and Technical analysis: Virax Biolabs Group Limited (VRAX)

In the last 20 days, the company’s Stochastic %K was 9.49% and its Stochastic %D was recorded 3.88%.

Now, considering the stocks previous presentation, multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -86.43%. The shares increased approximately by -28.41% in the 7-day charts and went up by -57.78% in the period of the last 30 days.

Leave a Comment

Your email address will not be published.

On Key

Related Posts